| Company Name: | Stryker Corporation | | Ticker Symbol: | SYK | | | WWW Address: | www.stryker.com | | CEO: | Stephen P. MacMillan | | No. of Employees: | 17,594 | | Common Issue Type: | CS | | Business Description: | a medical technology company, which provides a range of products in orthopaedics and a considerable presence in other medical specialties.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 48.73 |  -0.09 | 47.89 | 49.7 | 48.79 | 48.84 | 48.05 | 1427417 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 19,379.9 | 397.7 | 0.97 | 2.78 | 0.33 | 18.0 | 0.8 | 49.78 - 30.82 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 48.73 | $ | | PE Ratio - LTM | 18.0 | |
| Market Capitalisation | 19,381.8 | mil |
| Latest Shares Outstanding | 397.7 | mil |
| Earnings pS (EPS) | 2.78 | $ |
| Dividend pS (DPS) | 0.33 | ¢ |
| Dividend Yield | 0.8 | % |
| Dividend Payout Ratio | 12 | % |
| Revenue per Employee | 381,846 | $ |
| Effective Tax Rate | 27.4 | % |
| Float | 375.4 | mil |
| Float as % of Shares Outstanding | 94.4 | % |
| Foreign Sales | 2,436 | mil |
| Domestic Sales | 4,282 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 38.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 5.20 | % |
| Gross Profit Margin | 72.6 | % |
| EBITDA Margin | 29.2 | % |
| Pre-Tax Profit Margin | 22.4 | % |
| Assets Turnover | 0.8 | % |
| Return on Assets (ROA) | 12.8 | % |
| Return on Equity (ROE) | 16.8 | % |
| Return on Capital Invested (ROCI) | 16.8 | % |
| Current Ratio | 4.8 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 29.2 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 11.47 | $ |
| Cash pS | 2.41 | $ |
| Book-Value pS | 16.19 | $ |
| Tangible Book-Value pS | 13.79 | $ |
| Cash Flow pS | 3.65 | $ |
| Free Cash Flow pS | 2.58 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.01 | |
| Price/Tangible Book Ratio | 3.53 | |
| Price/Cash Flow | 13.3 | |
| Price/Free Cash Flow | 18.9 | |
| P/E as % of Industry Group | 64.0 | % |
| P/E as % of Sector Segment | 36.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 11/01/2009 |
| Dividend Ex-Date | 11/15/2009 |
| Dividend Record Date | 11/17/2009 |
| Dividend Pay Date | 12/15/2009 |
| Dividend Amount | 100 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.40 |
| Current Dividend Yield | 0.8 |
| 5-Y Average Dividend Yield | 0.5 |
| Payout Ratio | 12.0 |
| 5-Y Average Payout Ratio | 8.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.9 | 99 | 12,076 | 50,850 |
| 4 Weeks | 49.78 | 45.36 | 48.03 | 1.5 | 100 | 18,390 | 367,790 |
| 13 Weeks | 49.78 | 40.78 | 41.76 | 16.7 | 110 | 24,254 | 1,552,271 |
| 26 Weeks | 49.78 | 37.14 | 38.24 | 27.4 | 104 | 23,829 | 3,026,341 |
| 52 Weeks | 49.78 | 30.82 | 37.39 | 30.3 | 96 | 26,903 | 6,752,585 |
| YTD | 49.78 | 30.82 | - | 22.0 | 101 | 27,100 | 6,097,419 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 49.11 | 49.06 | 46.84 | 42.35 | 40.61 | 0.97 | 0.91 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 9.91 | 95.7 | 7.58 |
| Income | 19.90 | 92.4 | 13.12 |
| Dividend | 43.60 | 94.9 | 50.36 |
| Capital Spending | -1.60 | NA | -20.34 |
| R&D | 11.91 | NA | 4.02 |
| Normalized Inc. | 16.25 | NA | 13.43 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -2.2 | 0.0 | 12.0 |
| Earnings % | -7.9 | -16.4 | 12.8 |
| EPS % | -3.8 | -13.6 | 13.9 |
| EPS $ | -0.08 | -0.09 | 0.34 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 46.26 |
| Current Ratio | 3.4 |
| Quick Ratio (Acid Test) | 2.3 |
| Liquidity Ratio (Cash) | 1.50 |
| Receivables Turnover | 6.2 |
| Average Collection Period | 58 |
| Working Capital/Equity | 65.1 |
| Working Capital pS | 8.87 |
| Cash-Flow pS | 3.87 |
| Free Cash-Flow pS | 2.20 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 7.69 |
| Financial Leverage Ratio (Assets/Equity) | 1.4 |
| Debt Ratio | 28.9 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 13.6 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 31.0 |
| Interest/Capital Invested | 0.86 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 7.06 |
| Tobin's Q Ratio | 2.55 |
| Current P/E Ratio - LTM | 18.00 |
| Enterprise Value (EV)/EBITDA | 9.98 |
| Enterprise Value (EV)/Free Cash Flow | 27.45 |
| Dividend Yield | 0.8 |
| Price/Tangible Book Ratio - LTM | 3.53 |
| Price/Book Ratio - LTM | 3.01 |
| Price/Cash Flow Ratio | 13.3 |
| Price/Free Cash Flow Ratio - LTM | 18.9 |
| Price/Sales Ratio | 2.93 |
| P/E Ratio (1 month ago) - LTM | 16.8 |
| P/E Ratio (26 weeks ago) - LTM | 13.7 |
| P/E Ratio (52 weeks ago) - LTM | 13.5 |
| 5-Y High P/E Ratio | 50.6 |
| 5-Y Low P/E Ratio | 12.7 |
| 5-Y Average P/E Ratio | 28.7 |
| Current P/E Ratio as % of 5-Y Average P/E | 63 |
| P/E as % of Industry Group | 64.0 |
| P/E as % of Sector Segment | 36.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 16.5 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 3.69 |
| Tangible Book Value pS - LTM | 13.79 |
| Book Value pS - LTM | 16.19 |
| Capital Invested pS | 13.59 |
| Cash pS - LTM | 2.41 |
| Cash Flow pS - LTM | 3.65 |
| Free Cash Flow pS - LTM | 2.58 |
| Earnings pS (EPS) | 2.78 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 12.96 |
| Free Cash Flow Margin 5YEAR AVG | 9.92 |
| Net Profit Margin | 17.1 |
| Net Profit Margin - 5YEAR AVRG. | 15.0 |
| Equity Productivity | 1.24 |
| Return on Equity (ROE) | 21.2 |
| Return on Equity (ROE) - 5YEAR AVRG. | 19.5 |
| Capital Invested Productivity | 1.24 |
| Return on Capital Invested (ROCI) | 21.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 19.3 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 15.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | 13.7 |
| Gross Profit Margin | 72.6 |
| Gross Profit Margin - 5YEAR AVRG. | 71.9 |
| EBITDA Margin - LTM | 29.2 |
| EBIT Margin - LTM | 23.2 |
| Pre-Tax Profit Margin | 23.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 21.2 |
| Effective Tax Rate | 27.4 |
| Effective Tax Rate - 5YEAR AVRG. | 30.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 237 |
| Revenue per Employee | 381,846 |
| Net Income per Employee | 65,238 |
| Average Collection Period | 61 |
| Receivables Turnover | 6.2 |
| Day's Inventory Turnover Ratio | 176 |
| Inventory Turnover | 2.0 |
| Inventory/Sales | 14.2 |
| Accounts Payble/Sales | 4.08 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 1.91 |
| Fixed Assets Turnover | 2.56 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 9.58 |
| Revenue per $ Plant | 6.97 |
| Revenue per $ Common Equity | 1.24 |
| Revenue per $ Capital Invested | 1.24 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 39.1 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 38.7 |
| Research & Devlopment (R&D) as % of Revenue | 5.5 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 5.5 |
|
|  
|
| |
 |  |